Somaxon Pharmaceuticals, Inc.

(NASDAQ:SOMX)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 12,554 12,554 12,554 28,783
Cash At End Of Period 13,631 18,084 12,681 12,554
Net Change In Cash And Cash Equivalents 1,077 5,530 127 -16,229
Effect Of Exchange Rate Changes — — — —
Net Income Or Loss -27,774 -17,462 -7,066 -26,411
Cash From Operating Activities
Depreciation Expenses 88 59 30 115
Amortization Expenses — 70 63 -4
Amortization Of Intangibles Expenses — — — —
Deferred Income Taxes — — — —
Operating Gains Or Losses — — — 3
Extraordinary Gains Or Losses — — — —
Increase Or Decrease In Receivables — — — —
Increase Or Decrease In Inventories — — — —
Increase Or Decrease In Prepaid Expenses — — — —
Increase Or Decrease In Other Current Assets — — — —
Increase Or Decrease In Payables -462 — -1,717 -311
Increase Or Decrease In Other Current Liabilities 2,516 3,022 394 -4,557
Increase Or Decrease In Other Working Capital -701 -1,146 -952 1,025
Other Non Cash Items — -397 — 160
Net Cash From Continuing Operations 5,219 3,442 1,909 8,480
Net Cash From Discontinued Operations -21,114 -12,412 -7,339 -21,500
Net Cash From Operating Activities — — — —
Cash From Investing Activities
Sale Of Property Plant And Equipment — — — —
Sale Of Long Term Investments — — — —
Sale Of Short Term Investments — — — —
Purchase Of Property Plant And Equipment -389 -15 — -46
Acquisitions — — — —
Purchase Of Long Term Investments — — — —
Purchase Of Short Term Investments -13,091 -11,058 -6,088 -48,132
Other Investing Changes Net -7,500 -7,500 — —
Cash From Discontinued Investing Activities — — — —
Net Cash From Investing Activities 7,439 3,213 7,466 4,589
Cash From Financing Activities
Issuance Of Debt 25 2 — 682
Issuance Of Capital Stock — — — —
Repayment Of Debt -50 -50 — —
Repurchase Of Capital Stock — — — —
Payment Of Cash Dividends — — — —
Net Other Financing Charges — — — —
Cash From Discontinued Financing Activities — — — —
Net Cash From Financing Activities 14,752 14,729 — 682